Zdrowie i gospodarka · 02/05/1997
FDA Publishes Draft Guideline on Impurities: Residual Solvents
The FDA is releasing a draft guideline on acceptable residual solvents in pharmaceuticals, developed under the ICH framework, to ensure patient safety and reduce toxic solvents in manufacturing.
Source: Federal Register — Food and Drug AdministrationOpen original release →